We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$130M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$81.7M
3
SPIB icon
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
+$44.4M
4
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$38M
5
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$32M

Top Sells

Rank Stock Value
1
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$361M
2
MU icon
Micron Technology
MU
+$160M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$136M
4
AAPL icon
Apple
AAPL
+$49.2M
5
TSLA icon
Tesla
TSLA
+$44.7M

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMRE icon
3451
Costamare
CMRE
$1.76B
$22.5K ﹤0.01%
1,602
-1,928
-55% -$31.6K
BALY icon
3452
Bally's
BALY
$707M
$22.4K ﹤0.01%
1,635
-820
-33% -$10.5K
RNGR icon
3453
Ranger Energy Services
RNGR
$363M
$22.4K ﹤0.01%
1,396
-510
-27% -$8.36K
MBOT icon
3454
Microbot Medical
MBOT
$85.6M
$22.3K ﹤0.01%
11,448
+2,901
+34% +$5.91K
TBPH
3455
DELISTED
Theravance Biopharma
TBPH
$22.3K ﹤0.01%
1,313
+107
+9% +$1.77K
OSPN icon
3456
OneSpan
OSPN
$656M
$22.3K ﹤0.01%
1,553
-1,610
-51% -$20.3K
CMCL icon
3457
Caledonia Mining Corp
CMCL
$461M
$22.3K ﹤0.01%
1,166
-168
-13% -$3.81K
TRAK icon
3458
ReposiTrak
TRAK
$150M
$22.3K ﹤0.01%
2,473
+590
+31% +$5.39K
FOSL icon
3459
Fossil Group
FOSL
$367M
$22.2K ﹤0.01%
+5,370
New +$24.1K
VKTX icon
3460
Viking Therapeutics
VKTX
$4.43B
$22.2K ﹤0.01%
569
-8,999
-94% -$291K
CRMD icon
3461
CorMedix
CRMD
$612M
$22.2K ﹤0.01%
2,823
-3,539
-56% -$28K
SWMR
3462
Swarmer Inc
SWMR
$330M
$22.1K ﹤0.01%
498
+294
+144% +$12.7K
LTRX icon
3463
Lantronix
LTRX
$329M
$22K ﹤0.01%
3,749
+211
+6% +$1.35K
TWIN icon
3464
Twin Disc
TWIN
$380M
$22K ﹤0.01%
950
+803
+546% +$14.7K
GUTS icon
3465
Fractyl Health
GUTS
$77.3M
$21.9K ﹤0.01%
+27,628
New +$19.7K
EPSN icon
3466
Epsilon Energy
EPSN
$180M
$21.9K ﹤0.01%
4,052
+2,193
+118% +$13K
CAST
3467
FreeCast Inc
CAST
$56.6M
$21.9K ﹤0.01%
+3,262
New +$9.61K
AVXL icon
3468
Anavex Life Sciences
AVXL
$221M
$21.9K ﹤0.01%
8,463
-6,085
-42% -$18K
RIVN icon
3469
Rivian
RIVN
$22.4B
$21.9K ﹤0.01%
1,262
-24,706
-95% -$385K
OPRT icon
3470
Oportun Financial
OPRT
$393M
$21.9K ﹤0.01%
3,829
+903
+31% +$4.84K
LFCR icon
3471
Lifecore Biomedical
LFCR
$159M
$21.9K ﹤0.01%
4,164
-1,647
-28% -$8.3K
MYGN icon
3472
Myriad Genetics
MYGN
$399M
$21.8K ﹤0.01%
3,813
-16,589
-81% -$75.3K
MESO
3473
Mesoblast
MESO
$1.96B
$21.7K ﹤0.01%
1,607
-812
-34% -$12.1K
RNAC icon
3474
Cartesian Therapeutics
RNAC
$224M
$21.7K ﹤0.01%
2,084
+337
+19% +$2.5K
LTBR icon
3475
Lightbridge
LTBR
$241M
$21.7K ﹤0.01%
2,467
-2,969
-55% -$33.4K
137 138
139
140 141

Similar funds

AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 44.45% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.